Cargando…
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma
The inhaled corticosteroid fluticasone furoate (FF) and the long-acting β(2) agonist vilanterol (VI) are in development as a combined once-daily therapy for asthma and chronic obstructive pulmonary disease. Our study objectives were to compare the efficacy and safety of once-daily FF/VI with FF alon...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938760/ https://www.ncbi.nlm.nih.gov/pubmed/24136330 http://dx.doi.org/10.1183/09031936.00064513 |